Cytosorbents Crp Stock Analysis

Cytosorbents Stock Analysis Notes

About 33.0% of the company shares are held by institutions such as insurance companies. The book value of Cytosorbents Crp was currently reported as 0.24. The company recorded a loss per share of 0.36. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. Cytosorbents Cor operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people. For more info on Cytosorbents Crp please contact the company at 732 329 8885 or go to https://www.cytosorbents.com.

Cytosorbents Crp Investment Alerts

Cytosorbents Crp Upcoming and Recent Events

Cytosorbents Largest EPS Surprises

View All Earnings Estimates

Cytosorbents Stock Institutional Investors

Note, although Cytosorbents Crp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cytosorbents Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.77 M.

Cytosorbents Profitablity

The company has Profit Margin (PM) of (0.49) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.46.

Management Efficiency

Cytosorbents Crp has return on total asset (ROA) of (0.2793) % which means that it has lost $0.2793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.185) %, meaning that it created substantial loss on money invested by shareholders. Cytosorbents Crp's management efficiency ratios could be used to measure how well Cytosorbents Crp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.61. In addition to that, Return On Capital Employed is likely to grow to -0.77. At this time, Cytosorbents Crp's Total Assets are very stable compared to the past year. As of the 29th of November 2024, Non Current Assets Total is likely to grow to about 28.9 M, while Total Current Assets are likely to drop about 17.6 M.

Technical Drivers

As of the 29th of November, Cytosorbents Crp shows the Risk Adjusted Performance of 0.0059, mean deviation of 4.03, and Standard Deviation of 6.1. Cytosorbents Crp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cytosorbents Crp Price Movement Analysis

Cytosorbents Crp Insider Trading Activities

Cytosorbents Crp Outstanding Bonds

Cytosorbents Crp Predictive Daily Indicators

Cytosorbents Crp Forecast Models

Cytosorbents Crp's time-series forecasting models are one of many Cytosorbents Crp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cytosorbents Crp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cytosorbents Crp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cytosorbents shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cytosorbents Crp. By using and applying Cytosorbents Stock analysis, traders can create a robust methodology for identifying Cytosorbents entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cytosorbents analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cytosorbents analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cytosorbents Crp stock analysis indicators help investors evaluate how Cytosorbents Crp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cytosorbents Crp shares will generate the highest return on investment. By understating and applying Cytosorbents Crp stock analysis, traders can identify Cytosorbents Crp position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.